Cargando…

Dose‐linearity of the pharmacokinetics of an intravenous [(14)C]midazolam microdose in children

AIMS: Drug disposition in children may vary from adults due to age‐related variation in drug metabolism. Microdose studies present an innovation to study pharmacokinetics (PK) in paediatrics; however, they should be used only when the PK is dose linear. We aimed to assess dose linearity of a [(14)C]...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Groen, Bianca D., Vaes, Wouter H., Park, B. Kevin, Krekels, Elke H.J., van Duijn, Esther, Kõrgvee, Lenne‐Triin, Maruszak, Wioleta, Grynkiewicz, Grzegorz, Garner, R. Colin, Knibbe, Catherijne A.J., Tibboel, Dick, de Wildt, Saskia N., Turner, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783587/ https://www.ncbi.nlm.nih.gov/pubmed/31269280 http://dx.doi.org/10.1111/bcp.14047

Ejemplares similares

Successful Use of [(14)C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism
por: Mooij, Miriam G., et al.
Publicado: (2017)

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
por: van Groen, Bianca D., et al.
Publicado: (2020)

Quantifying the Pharmacodynamics of Morphine in the Treatment of Postoperative Pain in Preverbal Children
por: Goulooze, Sebastiaan C., et al.
Publicado: (2021)

Proof of Concept: First Pediatric [(14)C]microtracer Study to Create Metabolite Profiles of Midazolam
por: van Groen, Bianca D., et al.
Publicado: (2020)

Pediatric Microdose Study of [(14)C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept
por: Mooij, Miriam G., et al.
Publicado: (2014)

Supervised Multidimensional Item Response Theory Modeling of Pediatric Iatrogenic Withdrawal Symptoms
por: Goulooze, Sebastiaan C., et al.
Publicado: (2019)

Midazolam Infusion and Disease Severity Affect the Level of Sedation in Children: A Parametric Time-to-Event Analysis
por: Upadhyay, Parth J., et al.
Publicado: (2021)

Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
por: Brussee, Janneke M., et al.
Publicado: (2017)

Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants
por: Krekels, Elke H. J., et al.
Publicado: (2015)

Systematic Evaluation of the Descriptive and Predictive Performance of Paediatric Morphine Population Models
por: Krekels, Elke H. J., et al.
Publicado: (2010)

First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates
por: Brussee, Janneke M., et al.
Publicado: (2018)

Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children
por: Goulooze, Sebastiaan C., et al.
Publicado: (2021)

Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach
por: Brussee, Janneke M., et al.
Publicado: (2018)

A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children
por: Brussee, Janneke M., et al.
Publicado: (2019)

Children Are Not Small Adults, but Can We Treat Them As Such?
por: Krekels, Elke H.J., et al.
Publicado: (2019)

Exploring the Relationship Between Morphine Concentration and Oversedation in Children After Cardiac Surgery
por: Valkenburg, Abraham J., et al.
Publicado: (2020)

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
por: Mooij, Miriam G., et al.
Publicado: (2015)

Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory
por: Calvier, Elisa A. M., et al.
Publicado: (2018)

Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
por: Calvier, Elisa A. M., et al.
Publicado: (2016)

A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-Span
por: Wang, Chenguang, et al.
Publicado: (2012)

Daily interruption of sedation in critically ill children: study protocol for a randomized controlled trial
por: Vet, Nienke J, et al.
Publicado: (2014)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation
por: Wu, Yunjiao, et al.
Publicado: (2023)

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial
por: de Hoogd, Sjoerd, et al.
Publicado: (2014)

Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic Model
por: Völler, Swantje, et al.
Publicado: (2019)

The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties
por: Cristea, Sinziana, et al.
Publicado: (2020)

Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
por: de Wildt, Saskia N., et al.
Publicado: (2009)

Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport
por: van Groen, Bianca D., et al.
Publicado: (2020)

Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method
por: Calvier, E. A. M., et al.
Publicado: (2019)

Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
por: Takkis, Kalev, et al.
Publicado: (2017)

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments
por: Calvier, Elisa A. M., et al.
Publicado: (2018)

The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
por: Cristea, Sînziana, et al.
Publicado: (2020)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

A randomized controlled trial of daily sedation interruption in critically ill children
por: Vet, Nienke J., et al.
Publicado: (2015)

Short- and long-term impact of remifentanil on thermal detection and pain thresholds after cardiac surgery: A randomised controlled trial
por: de Hoogd, Sjoerd, et al.
Publicado: (2019)

Morphine Pharmacodynamics in Mechanically Ventilated Preterm Neonates Undergoing Endotracheal Suctioning
por: Välitalo, PA, et al.
Publicado: (2017)

Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
por: Breithaupt, Mareile H., et al.
Publicado: (2022)

Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults
por: van Rongen, Anne, et al.
Publicado: (2017)

The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
por: Brill, Margreke J., et al.
Publicado: (2015)

Ontogeny of midazolam glucuronidation in preterm infants
por: de Wildt, Saskia N., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_adb20mgiqhv5oo2an5kvvbs73j